Janseen

Janssen funds cancer study using VitalConnect, physIQ tech

By Laura Lovett 03:22 pm July 17, 2018

VitalConnect and physIQ are teaming up with the Haga Teaching Hospital in the Netherlands to conduct a study on how wearable biosensors and artificial intelligence can augment care for cancer patients undergoing treatment. Specifically, the study — which is funded by Johnson & Johnson subsidiary Janssen Pharmaceuticals — is looking to see how the technology can detect adverse events in cancer...

Janssen launches Care4Today mobile medication reminder system

By Neil Versel 04:18 am July 26, 2012

Janssen Healthcare Innovation, an entrepreneurial unit of pharmaceutical heavyweight Johnson & Johnson, is promoting medication adherence with a new secure messaging platform and smartphone app and website. The Care4Today Mobile Adherence program, announced on Wednesday, delivers reminders to take medications as directed, refill prescriptions and visit physicians when appropriate. Users can...